PATIENT NO : 16011927 SAMPLE No : 01023405

NAME : SANTA BAR SINGH THAPA SAMPLE COLLECTED : 25/09/2022 10:15:12

AGE/GENDER : 66 Y / Male REPORT AUTHORISED : 25/09/2022 11:55:24
REFERRED BY : Self
Page : 1/2

LABORATORY REPORT
* CPT Code Test (Method) - Sample Type Result Units Flag Reference Range

HAEMATOLOGY
Complete blood count (CBC)
83010 Hemoglobin 13.9 g/dL 13.0-17.0
(Automated cell counter) - EDTA

Total Leucocyte Count 5790 Cells / Cumm 4000-10000

(Automated Cell Counter Electrical
Impedance Method) - EDTA

DIFFERENTIAL COUNT
Polymorphs 45 % 40 - 70

Lymphocytes 37 % 20 - 45

Eosinophils 1 % 1-8

Monocyte 15 % 2 - 15

Basophils 2 % less than 2

PACKED CELL VOLUME (HCT) 40.4 % 40.0-50.0

(Automated cell counter) - EDTA

RBC Count 4.48 millions / L 4.5-5.5

(Automated Cell Counter Electrical cumm
Impedance Method) - EDTA

MCV 90.2 fl 83.0-101.0

(Calculated) - EDTA

MCH 31.1 pg 27.0-32.0

(Calculated) - EDTA

MCHC 34.5 g/dL 31.5-35.5

(Calculated) - EDTA

85049 Platelet Count 1.50 Lakhs / Cumm 1.5 - 4.5

(Automated Cell Counter Electrical
Impedance Method) - EDTA

IMMUNOLOGY
84153 Prostate Specific Antigen (PSA) Total 2.076 ng/ml <4.0
(Chemiluminescence) - Serum
Interpretation : Total PSA (tPSA):

This test is indicated for screening of asymptomatic men for early prostate cancer, monitoring patients with low-risk
prostate cancer undergoing active surveillance, monitoring the response to treatment with antibiotic in patients with
prostatitis and to evaluate the patients having prostate related symptoms
Elevated tPSA levels occur in benign prostatic hyperplasia, prostate cancer and acute prostatitis.
Men are recommended to undergo prostate biopsy in case of significant tPSA increase (using the same tPSA assay) or
if at least one of the following criteria is present:
• tPSA of = 10 µg/L in asymptomatic men

** not under the scope of accreditation Contd

PATIENT NO : 16011927 SAMPLE No : 01023405
NAME : SANTA BAR SINGH THAPA SAMPLE COLLECTED : 25/09/2022 10:15:12
AGE/GENDER : 66 Y / Male REPORT AUTHORISED : 25/09/2022 11:46:39
REFERRED BY : Self
Page : 2/2

LABORATORY REPORT
* CPT Code Test (Method) - Sample Type Result Units Flag Reference Range
• tPSA of 4–10 µg/L and pathologic free to total PSA
ratio
• A suspicious digital rectal examination.

Reference
1.Ferraro S, Bussetti M, Panthegini M. Serum prostate specific antigen testing for early detection of prostate cancer:
managing the gap between clinical and laboratory practice. Clin Chem 2021; 67 (4): 602–9

SEROLOGY
Dengue NS1 Antigen and IgG/IgM Antibody (Combo Panel)
NS1 Antigen Positive

Dengue IgG Negative

Dengue IgM Negative

Interpretation : Dengue NS1 Antigen and IgG/IgM- Clinical Information and Limitations

These assays detect both IgG and IgM class antibodies against all four Dengue fever virus types and Dengue antigen
(NS1). Except for very early IgM responses, the immune response to Dengue fever is not type specific. As with most
serological assays, paired testing of acute and convalescent samples is preferred. This is especially important when the
acute phase sample is taken within the first six days following onset. In most patients, Dengue antibodies are
detectable after the sixth day following the onset of symptoms. Cross reactivity with other flavi viruses is known to
occur. The extent and degree of cross reaction varies.

For the primary and secondary infection, the overall sensitivity is 95.8%, the overall specificity is >99.0%, and the
overall accuracy is 99.3%. For Dengue NS1, relative sensitivity is 95.6% and relative specificity is 95.5%. If the
symptom persists, while the result of Dengue NS1 rapid test is negative or non-reactive result, it is recommended to
resample the patient few days later or test with an alternative test device such as PCR, ELISA.False Positive Causes:-
Flavi Virus, Zika Virus, Chikungunya Fever, Hematological Malignancies, Viral Infections Japanese Encephalitis, HIV,
Severe Gram Negative Sepsis, Systemic Inflammatory disoder.
For Positive Cases; ELISA or PCR is advised for Confirmation.

--- End of Report ---

Validated By
Dr.Keyoor Gautam
MBBS,MD - PATHOLOGY
NMC No: 5305

** not under the scope of accreditation